Contamination of nurses' gloves with 5-fluorouracil: Study in eight cancer treatment centres;Médicaments cytotoxiques: Évaluation de l'impact de la purge des lignes de perfusion sur l'exposition du personnel infirmier

Archives des Maladies Professionnelles et de Medecine du Travail

Volumn 65, Issue 1, 2004, Pages 9-17

  Gilles, L ^a   Favier, B ^a   Lombard, I ^a   Ardiet, C ^a   Boufercha, R ^b   Catros, F ^c   Eppling, I ^d   Fourmaintraux, D ^e   Gondran, C ^f   Merle, J L ^g   Pelletier, A ^h   Roussel, A ^h   Latour, J F ^a  

^a CENTRE LÉON BÉRARD   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c INSTITUT CLAUDIUS REGAUD   (France)

^d CENTRE ALEXIS VAUTRIN   (France)

^e CENTRE OSCAR LAMBRET   (France)

^f CENTRE RENÉ HUGUENIN   (France)

^g CENTRE JEAN PERRIN   (France)

^h INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; FLUOROURACIL; SOLVENT;

ARTICLE; CANCER CENTER; CONTAMINATION; DRUG CONTAMINATION; GLOVE; HEALTH CARE PERSONNEL; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFUSION SYSTEM; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; ULTRAVIOLET RADIATION;

EID: 11144354037     PISSN: 12503274     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Falck K., Grohn P., Sorsa M., et al.: Mutagenicity in urine of nurses handling cytostatic drugs. Lancet, 1979, 1 (8128), 1250-1251.
2. Burgaz S., Karahalil B., Bayrak P., et al.: Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics. Mutat Res, 1999, 439, 97-104.
3. Ensslin A.S., Pethran A., Schierl R., et al.: Urinary platinum in hospital personnel occupationally exposed to platinum-containing antineoplastic drugs. Int Arch Occup Environ Health, 1994, 65, 339-342.
4. Ensslin A.S., Stoll Y., Pethran A., et al.: Biological monitoring of cyclophosphamide and ifosfamide in urine of hospital personnel occupationally exposed to cytostatic drugs. Occup Environ Med, 1994, 51, 229-233.
5. Hirst M., Tse S., Mills D.G., et al.: Occupational exposure to cyclophosphamide. Lancet, 1984, 1 (8370), 186-188.
6. Nygren O., Lundgren C.: Determination of platinum in workroom air and in blood and urine from nursing staff attending patients receiving cisplatin chemotherapy. Int Arch Occup Environ Health, 1997, 70, 209-214.
7. Sessink P.J.M., Boer K.A., Scheefhals A.P.H., et al.: Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health, 1992, 64, 105-112.
8. Turci R., Sottani C., Ronchi A., et al.: Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett, 2002, 134, 57-64.
9. Venitt S., Crofton-Sleigh C., Hunt J., et al.: Monitoring exposure of nursing and pharmacy personnel to cytotoxic drugs: urinary mutation assays and urinary platinum as markers of absorption. Lancet, 1984, 1 (8368), 74-77.
10. Sessink P.J.M., Van De Kerkhof M.C.A., Anzion R.B.M., et al.: Environmental contamination and assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: is skin absorption an important exposure route? Arch Environ Health, 1994, 49, 165-169.
11. Selevan S.G., Lindbohm M.L., Hornung R.W., et al.: A study of occupational exposure to antineoplastic drugs and fetal loss in nurses. N Engl J Med, 1985, 313, 1173-1178.
12. Valanis B., Vollmer W.M., Steele P.: Occupational exposure to antineoplastic agents: self-reported miscarriages and still-births among nurses and pharmacists. J Occup Environ Med, 1999, 41, 632-638.
13. Hemminki K., Kyyrönen P., Lindbohm M.L.: Spontaneous abortions and malformations in the offspring of nurses exposed to anaesthesic gazes, cytostatic drugs, and other potential hazards in hospital, based on registered information of outcome. J Epidemiol Comm Health, 1985, 39, 141-147.
14. Lorente C., Cordier S., Bergeret A., et al.: Maternal occupational risk factors for oral clefts. Scand J Work Environ Health, 2000, 26, 137-145.
15. Gunnarsdottir H.K., Aspelund T., Karlsson T., et al.: Occupational risk factors for breast cancer among nurses. Int J Occup Environ Health, 1997, 3, 254-258.
16. Skov T., Maarup B., Olsen J., et al.: Leukaemia and reproductive outcome among nurses handling antineoplastic drugs. Br J Ind Med, 1992, 49, 855-861.
17. Gamelin E., Boisdron-Celle M., Turcan A., et al.: Rapid and sensitive high-performance liquid chromatographic analysis of halogenopyrimidines in plasma. Chromatogr B Biomed Sci Appl, 1997, 695, 409-416.
18. Favier B., Rull F., Bertucat H., et al.: Évaluation de la contamination de l'environnement matériel et humain par le 5-fluoro-uracile lors de la manipulation en unités de reconstitution des chimiothérapies. J Pharm Clin, 2001, 20, 157-162.
19. Leboucher G., Serratrice F., Bertholle V., et al.: Évaluation de la contamination par le platine d'une unité centralisée de préparation des médicaments cytotoxiques. Bull Cancer, 2002, 89, 949-955.
20. Favier B., Latour J.F., Ardiet C., et al.: Évaluation de la contamination des gants et des mains du personnel infirmier avant et après formation à la manipulation des anticancéreux. Arch Mal Prof, 2002, 63, 20-24.
21. Connor T.H., Anderson R.W., Sessink P.J.M., et al.: Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States. Am J Health-Syst Pharm, 1999, 56, 1427-1432.
22. Mc Dewitt J.J., Lees P.S.J., Mc Diarmid M.A., et al.: Exposure of hospital pharmacists and nurses to antineoplastic agents. J Occup Med, 1993, 35, 57-60.
23. Favier B., Gilles L., Latour J.F.: Mise en place d'un système d'évaluation des manipulateurs dans une unité de reconstitution de cytotoxiques. J Pharm Clin, 2003, 22, 107-112.